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2Abbreviations
AMPA -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
AP-5 D(-)-2-amino-5-phosphonovaleric acid
cAMP cyclic adenosine monophosphate
eEPSC(s) evoked excitatory postsynaptic current(s)
EP early phase (of the forskolin-induced potentiation)
EPSC(s) excitatory postsynaptic current(s)
LP late phase (of the forskolin-induced potentiation)
LTP long-term potentiation
mEPSC(s) miniature excitatory postsynaptic current(s)
NMDA N-methyl-D-aspartic acid
PKA protein kinase A
PKI protein kinase A inhibitor peptide, 6-22 amide
Rp-cAMPS  adenosine 3,5-monoaminophosphorothioate, Rp-isomer
TTX tetrodotoxin
3Abstract.
It has been demonstrated that stimulation of protein kinase A (PKA) results in enhanced
synaptic transmission in the hippocampus and other brain areas. To investigate 
mechanisms of the PKA-mediated potentiation of synaptic transmission, we used rat 
hippocampal embryonic cultures. In low-density cultures, paired recordings under the
perforated patch demonstrated that 15 min forskolin treatment produced long-lasting 
potentiation of evoked EPSCs (eEPSCs) mediated by the cAMP/PKA pathway. eEPSC 
amplitudes increased to 240±10 % of baseline after 15 min of forskolin treatment (early 
potentiation). After forskolin washout, eEPSCs declined to a potentiated level. 
Potentiation was sustained for at least 85 min after forskolin washout and, 60 min after 
forskolin washout, constituted 152±7% of baseline (late potentiation). Disruption of 
presynaptic processes with the whole-cell configuration and internal solution containing 
PKA inhibitor peptide did not affect forskolin-induced potentiation. Disruption of 
postsynaptic processes, in contrast, impaired early potentiation and abolished late 
potentiation. Study of mEPSCs confirmed the contribution of postsynaptic mechanisms. 
Forskolin-induced enhancement of mEPSC frequency observed under the perforated 
patch was attenuated by the whole-cell configuration. Forskolin also induced an increase 
of mEPSC amplitudes in the perforated patch, but not in the whole-cell, experiments. 
Potentiation of eEPSCs was not activity dependent, persisting in the absence of 
stimulation. NMDA receptor blockade did not abolish forskolin-induced potentiation. In 
summary, we demonstrate that forskolin-induced potentiation of eEPSCs was mediated 
by postsynaptic mechanisms, presumably via upregulation of AMPA receptors by 
phosphorylation.
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5Introduction.
Long-term potentiation (LTP) is a long-lasting, use-dependent increase of the 
effectiveness of synaptic transmission. Since LTP is believed to mediate memory 
formation, activity-induced LTP and its underlying mechanisms have been subjects of 
intensive research efforts. A substantial body of evidence implicates cAMP-dependent 
protein kinase (PKA) in the production and maintenance of LTP. For example, LTP 
induced by repeated tetanic stimulation of hippocampal neurons is accompanied by PKA 
activation (Huang and Kandel 1994; Roberson and Sweatt 1996). Inhibitors of PKA 
block or decrease LTP, and activators of PKA facilitate LTP in the CA3 and CA1 areas 
of the hippocampus (Frey et al. 1993; Huang and Kandel 1994; Huang et al. 1994; 
Matthies and Reymann 1993; Otmakhova et al. 2000). The role of PKA in LTP and 
memory has also been demonstrated using genetic approaches (Abel et al. 1997; Huang et 
al. 1995; Qi et al. 1996). 
It is widely known that not only is PKA involved in LTP, but, when directly
stimulated, it also produces a marked enhancement of synaptic efficacy (Carroll et al. 
1998; Chavez-Noriega and Stevens 1994, 1992; Chen and Roper 2003; Greengard et al. 
1991). Because of the involvement of PKA in LTP and memory, numerous attempts have 
been undertaken to elucidate mechanisms through which PKA might modify the synaptic 
strength. A large body of evidence suggests that the change of synaptic efficacy might be 
contributed by modulation of both presynaptic and postsynaptic PKA substrates. Early 
studies have demonstrated that PKA modulates the AMPA receptor function (Banke et al. 
2000; Chavez-Noriega and Stevens 1992; Greengard et al. 1991; Roche et al. 1996; 
Wang et al. 1991; Wang et al. 1993). Activation of PKA is associated with an increase of 
6the number of functional release sites in cultured neurons isolated from a dissociated 
dentate gyrus, and in the CA1 area of the hippocampus (Kohara et al. 2001; Ma et al. 
1999). PKA also increased a kainate-sensitive transmitter release in mossy fibers 
(Goussakov et al. 2000).
Despite a potential involvement of AMPA receptors, electrophysiological studies 
failed to demonstrate a contribution of postsynaptic mechanisms to the effect of PKA 
activators on synaptic transmission. For example, Carroll et al. have reported that 
forskolin dramatically increased the frequency of miniature excitatory postsynaptic 
currents (mEPSCs) in CA1 pyramidal neurons of the hippocampus but did not change 
mEPSC amplitudes (Carroll et al. 1998), leading to a conclusion about the presynaptic 
locus of forskolin action. A similar result has been reported by Chavez-Noriega and 
Stevens (Chavez-Noriega and Stevens 1994). 
Analysis of synaptic currents obtained during electrophysiological recording has 
being performed using postulates of the classical quantal theory. Classical quantal theory 
was introduced by Del Castillo and Katz in their study of transmission at the  
neuromuscular junction (Del Castillo and Katz 1954). According to this theory, the 
frequency of mEPSCs at each synapse is determined by the probability of releasing a 
single quantum (interpreted as a vesicle) and the number of releasable quanta. At the 
neuromuscular junction, studied by Del Castillo and Katz, the number of quanta and 
active synapses remains unchanged throughout the experiment. Consequently, a change 
of mEPSC frequency has been thought to reflect a changed probability of 
neurotransmitter release.
7The validity of some postulates on the nature of synaptic transmission, established 
by Del Castillo and Katz, remains questionable for central synapses. For example, the 
number of active synapses changes during some forms of LTP (Faber et al. 1991; Isaac et 
al. 1995). This change, via postsynaptic mechanisms, affects the frequency of mEPSCs, 
vitiating the conventional view that mEPSC frequency reflects only presynaptic changes. 
Thus, conclusions about the presynaptic origin of PKA-mediated changes at central 
synapses, derived from the analysis of mEPSCs, should be re-examined.
To further investigate the locus of expression of PKA-mediated potentiation, we 
examined the effect of forskolin on eEPSCs and mEPSCs in rat embryonic hippocampal 
cultured neurons. By manipulating the method used to gain a control over the cell 
membrane potential in patch clamp experiments (perforated patch or whole-cell voltage 
clamp), we demonstrate that forskolin-induced potentiation is mediated by postsynaptic 
mechanisms. 
8Experimental procedures.
Neuronal culture. Rat hippocampal embryonic cultures were prepared as 
described (Li et al. 1998). Briefly, hippocampi isolated from Wistar rat embryos at day 
18 of gestation (E18) were treated with papain (20mM) for 15 min at 36°C, and then 
dissociated by trituration and plated on glass coverslips precoated with 
polyethyleneimine. Cells for mEPSC and paired recordings were plated at a density 200 
cells/mm2 (high-density cultures) and 140 cells/mm2 (low-density cultures), respectively. 
Cultures were maintained at 36°C in a 5% CO2 incubator and were grown in Neurobasal 
medium (Gibco) supplemented with B27 (Gibco, a complex of vitamins and neurotrophic 
factors), 0.5 mM Glutamax (Gibco) and glutamate each, and 5% horse serum. Low-
density culture medium also contained 1.5 mM more Gln and 15 mM more KCl. All 
components of the culture medium were purchased from Invitrogen. As glia formed a 
monolayer 5-6 days after plating, an anti-mitotic agent 1-ß-D-arabinofuranosylcytosine
(Sigma) was added to the medium to 0.05% final concentration to inhibit further glial 
growth. Half of the medium in the dish was then substituted by fresh serum-free medium 
once every week. Cultures used for paired or mEPSC recordings were 18-20 and 23-25 
days old, respectively. 
Electrophysiology. A glass coverslip with cultured neurons was placed into a 
perfusion chamber with a solution volume 0.2-0.5 ml. Perfusion rate was set at 0.5-1 
ml/min. All experiments were done at room temperature. The following is a composition 
of the bathing solution used in experiments (in mM): NaCl 145, KCl 5, MgCl 0.5, CaCl2
2, HEPES 5, glucose 10, pH 7.4. For mEPSC recordings the bath was supplemented with 
0.5 µM tetrodotoxin (TTX). When indicated, the superfusion medium contained 50 
9µmol/l forskolin. The pipette solution used for perforated patch experiments contained (in 
mM): potassium gluconate 150, NaCl 5, EGTA 0.1, HEPES 5, pH 7.2. Right before the 
experiment, Amphotericin B (Calbiochem) was dissolved in dimethylsulfoxide at a 
concentration 60 mg/ml. This Amphotericin B stock was added to the pipette solution to 
create 1.5 mg/ml final concentration. Electrode resistance was 4-6 M. Access resistance 
stabilized during the first 10-15 min of experiments and ranged from 18 to 30 M. Cells 
were voltage-clamped at -60 mV or -65 mV using Axopatch 200 or Axopatch 200A. The 
contribution of inhibitory currents during recordings of the tetrodotoxin-resistant 
spontaneous activity, was negligible, since the -80 mV membrane potential (-65 mV with 
the corrected liquid junction potential) was close to the reversal potential for chloride. In 
addition, picrotoxin (40 µM) did not significantly change the frequency of tetrodotoxin-
resistant spontaneous currents (4 experiments, data not shown). Pipette solution for the 
whole-cell experiments contained (in mM): potassium gluconate 150, NaCl 5, MgCl2 2, 
CaCl2 0.1, EGTA 5, HEPES 5, PKA inhibitor peptide 7-22 (PKI, Calbiochem) 0.015, pH 
7.2. Access resistance in the whole-cell experiments was in the range 15-25 M. Access 
resistance did not change more than 15% in mEPSC experiments and more than 20 % -
during paired recordings. 
Whole-cell current in mEPSC experiments was filtered at 2 kHz and digitized at 
10 kHz. mEPSCs were analyzed using a custom-made program. Asymmetric events with 
the rise time shorter than the decay time and amplitudes higher than 4 pA (the threshold 
for event detection) were chosen for the analysis. mEPSC frequency and amplitudes were 
established by analyzing a 90 - 300 s long records in the high-density and low-density 
cultures, respectively. Extending the analysis for longer periods in a number of 
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experiments did not significantly change the results. mEPSC frequency ranged between 
1.3 and 19 Hz in high-density cultures and 0.15 and 2.6 Hz in low-density cultures. The 
average number of events analyzed for each record was 475 ± 66(SE) in high-density 
cultures and 118 ± 25(SE) in low-density cultures.
For paired recordings two connected neurons were voltage-clamped using 
perforated patch configuration. One of the neurons was stimulated at 30 s intervals by 
applying a 1 ms voltage step to +20 mV. Postsynaptic currents induced within 2-4 ms 
after the stimulus were recorded for 25-30 min before the forskolin treatment, to establish 
the baseline level of eEPSC amplitudes. The eEPSC signals were filtered at 1 kHz and 
digitized at 5 kHz. 80% series resistance compensation was employed in all paired 
recording protocols. After forskolin washout, paired recordings continued for as long as 
the gigaseal remained intact. Baseline level was calculated as an average of eEPSC 
amplitudes during the 10 min preceding the forskolin application. During and after 
forskolin treatment eEPSC amplitudes in each experiment were normalized to the 
baseline level. In each group of experiments, results of paired recordings are presented as 
normalized eEPSCs averaged over a 2 min period.
Western blot. Cells were plated at a density 200 cells/mm2 in 35 mm Biocoat 
plastic dishes (BD, Franklin Lakes, NJ). After 24 days in culture cells were incubated 
with either a solution containing TTX, or a solution with TTX and forskolin, depending 
on the experiment. Whole-cell lysates were obtained by adding 400 µl lysis buffer to a 
dish. The following is a composition of the lysis buffer: 62.5 mM Tris pH 6.8, 1% SDS, 5 
% mercaptoethanol. PMSF (at a 1 mM final concentration) and Complete Mini Protease 
inhibitor cocktail tablets (Roche) were added to the lysis buffer just before the 
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experiments to prevent protein degradation and inhibit phosphatase activity. After short 
incubation in the lysis buffer, samples were collected and passed through a 26-gauge 
needle 10 times (to shear genomic DNA). Samples were then boiled for 5 min and placed 
on ice or stored in a -70°C freezer until use. 25 µl of each sample were loaded onto a 
precast 4-15% gradient SDS-TrisHCl gel (Bio-Rad Laboratories). Proteins were 
electrophoretically separated at 120 V for 2 h, and then blotted onto a nitrocellulose 
membrane (Bio-Rad Laboratories) at 100V for 1h. Membranes were washed with Tris 
buffered solution (TBS) and blocked with 5% fat free dry milk (Carnation) in TBS for 30 
min at room temperature. Blots were then incubated with rabbit anti-phospho-GluR1 
(Ser845) (Upstate, 1:4000 dilution) or rabbit anti-GluR1 (Upstate, 1:10,000 dilution) 
antibodies in 0.1% Tween-TBS for 3 h at room temperature. For negative control,
membranes were incubated with the Tween-TBS solution containing anti-
phospho(Ser845)-GluR1 antibody and a saturating concentration (1 µM) of phospho-
GluR1 immunizing peptide (Upstate). After two 5-min washes in Tween-TBS, blots were 
subjected to biotinylated anti-rabbit secondary antibodies (Vector Laboratories) for 1 h. 
After two additional washes HRP-conjugated streptavidin was applied (Vectastain ABC 
kit, Vector Laboratories) according to vendor instructions. Signal was detected using 
Vector NovaREDTM substrate kit for peroxidase (Vector Laboratories).
All salts and forskolin were purchased from Sigma.
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Results.
Perfusion with forskolin induced a long-lasting PKA-dependent potentiation of eEPSCs.
To investigate the effect of forskolin on eEPSC amplitudes we conducted dual-
cell voltage-clamp experiments in isolated pairs of neurons in a low-density culture (see 
methods), using the perforated patch configuration. Perfusion with forskolin (50 µ) for 
15 min substantially increased eEPSC amplitudes. The time course of the forskolin-
induced changes of eEPSCs could be divided into three phases. The first, early phase of 
potentiation (EP) took place during forskolin treatment. It is characterized by a gradual 
rise of eEPSC amplitudes to 240±10 % of baseline 15 min after the start of forskolin 
treatment; the change was observed in all 6 pairs tested. The second phase of eEPSC 
changes consisted of a decline of eEPSC amplitudes during the first 10 min of forskolin 
washout. eEPSCs then stabilized (at a still potentiated level) marking the third, late phase 
of potentiation (LP). LP was sustained for at least 85 min after forskolin washout (5 of 6 
tested cell pairs). 60 min after forskolin washout, eEPSC amplitudes averaged 152±7 % 
of baseline. The results of these experiments are summarized in Fig 1a.
To test whether forskolin action was mediated by the adenylyl cyclase/PKA 
pathway, neuronal cultures were subjected to Rp-cAMPS (50 µM) 1 h prior to forskolin 
treatment. This drug was continuously present in a perfusion medium during the 
experiments. Rp-cAMPS is a membrane-permeable non-hydrolyzable cAMP analogue 
which associates with the cAMP-binding site of PKA, thus blocking PKA activity. Rp-
cAMPS abolished the LP (3 cell pairs), indicating that forskolin acted through the PKA 
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(Fig.1a). However, despite the presence of the PKA inhibitor, there was a 36±17% 
increase of eEPSC amplitudes during the EP (Fig 1a). 
Forskolin increased frequency of mEPSCs.
It has been demonstrated that activation of PKA upregulates mEPSC frequency in
very young hippocampal cultures (Greengard et al. 1991) and in pyramidal neurons of the 
CA1 area of the hippocampus (Carroll et al. 1998; Chavez-Noriega and Stevens 1994). 
To verify that this is the case in our system, we recorded mEPSCs in high-density 
cultures using the perforated patch configuration. To establish whether the increase of 
mEPSC frequency is long-lasting and whether it contributes to the forskolin-induced LP, 
we performed long-term recordings of mEPSCs. Baseline level of mEPSC frequency was 
measured just prior to forskolin treatment. 15 min of forskolin treatment (50µmol/l) 
resulted in an enhancement of mEPSC frequency to 445±47% of the baseline (5 
experiments). This enhancement immediately after forskolin treatment was followed by a
decline of mEPSC frequency to 163±67% of the baseline during the first 15 min after
forskolin washout. Subsequently, mEPSC frequency declined more slowly, and reached
the baseline level 45 min after the start of forskolin washout. There was no detectable 
increase of mEPSC amplitudes (results not shown). The results of these experiments are 
shown in Fig. 1b. 
In control experiments, the time course of changes of mEPSC frequency was
monitored in untreated cultures. mEPSC frequency remained unchanged for the first 30 
min after being placed in the bathing solution, and then declined to 68±5% of baseline 60 
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min after the start of experiments (5 experiments, Fig 1b). Because access resistance 
changes could contribute to the observed decline of mEPSC frequency, in all the 
analyzed experiments access resistance of perforated patches was monitored and changed  
< 15% throughout the experiment. 
Whole-cell experiments reveal a postsynaptic locus of expression of the forskolin-
induced potentiation.
To determine whether presynaptic or postsynaptic events are the main 
contributing factors to the forskolin-induced potentiation, we uncoupled intracellular 
events in one of the neurons using the whole-cell patch-clamp configuration. By 
including PKI (see methods) in an ATP-deficient pipette solution, we attempted both to 
inhibit events that resulted from cytoplasmic factors, and  also to block the activity of the 
membrane-bound PKA.
In all 6 experiments done under the presynaptic whole-cell configuration, the EP 
of the forskolin-induced potentiation remained unchanged. During this phase, eEPSC 
amplitudes rose to 244±21% of baseline. In 4 of these 6 experiments neuronal pairs also 
displayed the LP at the level similar to the one observed under the perforated patch (153 
± 9 % of baseline 1 h after forskolin washout, 4 experiments, Fig 2a). In the other 2 
experiments, the EP was followed by gradual depression of eEPSC amplitudes upon 
forskolin washout.
As opposed to the forskolin effect under the presynaptic whole-cell, under the 
postsynaptic whole-cell configuration both EP and LP were either impaired or abolished. 
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During forskolin perfusion, eEPSCs rose to only 146±11(SE) % of baseline (4 cell pairs)
in these experiments. Forskolin washout was associated with a decline of eEPSC 
amplitudes back to the baseline level soon after the start of the washout. 60 min after 
forskolin washout, at times corresponding to LP, eEPSC amplitudes constituted 96±6(SE) 
% of baseline (4 experiments) (Fig 2a).
In control experiments using either the presynaptic or postsynaptic whole-cell 
configuration, we monitored eEPSCs in untreated cultures (2 experiments in each of 
configurations). These experiments demonstrated that a disturbance produced by the 
whole-cell configuration, by itself, does not affect basal synaptic transmission, making it 
possible to conduct long-term experiments using the whole-cell configuration (Fig. 2b).
Whole-cell configuration attenuated forskolin-induced enhancement of mEPSC 
frequencies.
To verify if postsynaptic events contributed to the forskolin-induced upregulation
of mEPSC frequency, we used the same strategy for disrupting postsynaptic events as in 
the previous set of experiments. A neuron in a high-density culture was voltage-clamped 
in the whole-cell configuration. The internal solution was supplemented with PKI. Under 
these conditions, 15 min forskolin treatment induced an enhancement of mEPSC 
frequency to 275±18(SE) % of baseline. mEPSC frequency then declined upon forskolin 
washout, reaching the baseline level 45 min after the start of washout. Thus, the time 
course of mEPSC frequency changes, produced by forskolin in these experiments, was 
similar to the one under the perforated patch. However, the increase of mEPSC frequency 
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during forskolin treatment was significantly lower than in perforated patch experiments 
(P<0.01). 
It has been noted in earlier studies that, under the whole-cell configuration,
miniature events undergo a substantial rundown, presumably due to the washout of 
essential cytoplasmic components (Wang et al. 1991). This baseline mEPSC rundown 
under the whole-cell configuration could contribute to an impairment of the forskolin-
induced upregulation of mEPSC frequency. Indeed, control experiments demonstrated 
that mEPSC frequency decreased by 37±8% of baseline during the first 30 min after 
formation of the whole-cell configuration (8 experiments). During the next 15 min,
however, the decline of mEPSC frequency was negligible (4.5±8 % of baseline, 8 
experiments) (Fig 3a). To minimize a contribution of mEPSC rundown under the whole-
cell configuration, forskolin was applied 30 min after the whole-cell formation, when the 
level of AMPA receptor rundown was minimal. The mEPSC frequency just prior to 
forskolin application was considered a baseline. In these experiments the increase of 
mEPSC frequency after 15 min of forskolin treatment was 294±25 % (5 experiments), 
similar to that in the previous set of experiments (275±18 %). 
Factors, other than differing patch-clamp configurations, could also contribute to 
the differing effect of forskolin on mEPSC frequency. Such factors are developmental 
differences or variability of the cell density between dishes or batches of neurons. To 
avoid a contribution of these artifacts we examined the effect of forskolin on mEPSCs
while recording simultaneously under the perforated patch and whole-cell using dual-
electrode voltage-clamp. In these experiments 30 min was allowed between the whole-
cell formation and forskolin application. The resulting increase of mEPSC frequency in 
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each individual experiment was consistently and significantly higher in neurons under the 
perforated patch compared to those under the whole-cell configuration (1.45±0.11 times,
p<0.05, 3 experiments). Examples of traces recorded during these experiments are shown 
in Fig 3b. 
Paired-pulse facilitation.
Paired-pulse facilitation (PPF) was not systematically studied, mainly because the
double-stimulus protocol occasionally led to the upregulation of baseline eEPSCs. In 
addition, during baseline recording, presynaptic neurons under the whole-cell 
configuration did not express PPF. This contrasts with the neurons under the perforated 
patch, 6 out of 8 of which expressed PPF. The average PPF in the perforated patch 
experiments was 1.65 ± 0.24 (8 experiments, 50 ms inter-pulse interval). Similarly, in 
experiments with the postsynaptic neuron under the whole-cell, the average PPF was 1.74 
± 0.22 (8 experiments).  None of the 6 presynaptic neurons under the whole-cell 
configuration expressed PPF. The average ratio of responses to the paired-pulse stimuli in 
these experiments was significantly lower than in two other sets of experiments (0.85 ±
12, p<0.01). Contrasting PPF in experiments using different patch-clamp configurations 
affirm that presynaptic terminals under the whole-cell were affected by the dialyzing
conditions of the experiment, presumably by PKI present in the pipette solution.
Forskolin-induced potentiation was independent of NMDA-receptors but associated with 
upregulation of AMPA receptors. 
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To verify whether forskolin treatment produced phosphorylation of the GluR1 
subunit of AMPA receptors, we used Western blot analysis. Western blots of the whole-
cell protein extracts, electrophoretically separated using SDS-PAGE, were 
immunostained with the anti-phospho-GluR1 antibody specific for phosphorylated 
Ser845 (anti-P-GluR1Ser845 antibody). High-density cultures were treated with forskolin 
for 15 min, and then lysed 0 or 45 min after the treatment. Control sample was obtained 
from untreated cultures. The 45 min period was chosen because it represents the 
approximate period of time that the mEPSC frequency, initially up-regulated by 
forskolin, returned to the baseline level.
The presence of an extra band only in the lane corresponding to cultures lysed 
immediately after forskolin treatment indicated that forskolin produced a new, short-lived 
phosphorylation state of the GluR1 (Fig. 4a, top panel). Specificity of the forskolin-
induced extra band was demonstrated by incubating the blots with the antibody-
containing medium supplemented with the anti-Ser845 phospho-GluR1 immunizing 
peptide (at a saturating concentration, 1µM). Under these conditions, the forskolin-
induced extra band did not appear in the Western blot (Fig 4a, middle panel). 
It has been reported that PKA increased the peak open probability of the AMPA 
receptor channel opening (Banke et al. 2000). This effect is expected to up-regulate
macroscopic currents through AMPA receptors, including mEPSCs. Despite an apparent 
increase of GluR1 phosphorylation as a result of forskolin treatment, the expected 
increase of mEPSC amplitudes was not observed in dense cultures (data not shown). We 
hypothesized that the increase of mEPSC amplitudes was undetectable due to the 
problems of dendritic filtering and a low signal-to-noise ratio in the dense cultures. To 
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obviate these problems we monitored changes of mEPSC amplitudes in low-density 
cultures. The filtering effect in such a system must be negligible, since a neuronal 
dendritic tree in low-density cultures is formed by few short dendrites. 
Average mEPSC amplitude in low-density cultures in the perforated patch 
experiments increased significantly as a result of forskolin treatment (by 29 ± 3 %, 
p<0.001, 3 experiments, two-sample t-test). This effect of forskolin on mEPSC 
amplitudes was disrupted by the whole-cell patch-clamp configuration. Analysis of 
mEPSC amplitudes as cumulative probabilities also demonstrated that, under the 
perforated patch, mEPSC amplitudes were significantly upregulated after 15 min 
forskolin treatment (p<0.05, Kolmogorov-Smirnov test, Fig 4b). The change of mEPSC 
amplitudes was short-term and reversed upon forskolin washout. 
To further investigate the mechanism of the forskolin-induced potentiation, we 
aimed at establishing whether synaptic activity during and after forskolin treatment was
essential for the effect of the drug on eEPSCs. For this purpose, after about half an hour 
of baseline eEPSC recording, paired stimulation was paused and was not resumed until 
40 min after forskolin washout. Under such conditions, eEPSC amplitudes, at times 
corresponding to LP, were even higher than those in experiments on continuously active
neuronal pairs (211±17 % of baseline, 3 experiments, vs. 152±7%, 5 experiments).
To decide whether NMDA receptors contributed to the forskolin-induced 
potentiation, we treated cultures with the NMDA-receptor blocker D(−)-2-Amino-5-
phosphonopentanoic acid (AP-5) (50 µM) for at least 1 h prior to experiments. During the 
experiments cultures were superfused with forskolin (50 µM) as well as with AP-5 (50 
µM). Both the EP and LP of the forskolin-induced potentiation of eEPSCs in these 
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experiments were unaffected by the NMDA-receptor blocker. With the background of 
AP-5, eEPSC amplitudes were 162±7% (3 experiments) 60 min after forskolin washout. 
The results of these experiments are presented in Fig 4c.
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Discussion.
In the present study, by comparing patch-clamp results in perforated and whole-
cell configurations, we demonstrated that forskolin produced a PKA-dependent LTP of 
synaptic transmission via postsynaptic mechanisms.  
Our strategy was to investigate the effect of forskolin in neurons minimally 
perturbed by experimental conditions, and to compare this effect to that in neurons
dialyzed from the inside using the whole-cell patch-clamp configuration. Under the 
perforated patch, most of intracellular molecules, including divalent ions, remain intact 
(Rae et al. 1991). The whole-cell configuration, in contrast, is associated with the
washout of intracellular components, including cytoplasmic proteins and ATP, and 
buffering intracellular calcium by EGTA present in the pipette solution (Marty & Neher, 
1995). Such conditions are expected to perturb, if not abolish, intracellular processes 
relying on cytoplasmic factors. To inhibit the activity of the membrane-bound PKA, 
which might not be washed out under the whole-cell configuration, we used an ATP-
deficient electrode solution supplemented with PKI.
It was essential to demonstrate that long-term changes of eEPSCs under the 
whole-cell configuration were not associated with the absence of ATP and the presence
of PKI in the pipette solution. In a control set of experiments, there was no significant 
change of eEPSC amplitudes for a prolonged period (> 80 min after the whole-cell 
formation) when either the presynaptic or the postsynaptic cell was dialyzed by the 
whole-cell configuration (Fig. 2 b). This result does not support the idea that  AMPA 
receptor-mediated currents are stabilized by internal ATP. The role of ATP was 
emphasized in the study by Wang et al. (1991). That group reported a partial rundown of 
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the whole-cell currents evoked by pressure application of 250 µM kainate to the soma of 
hippocampal cultured neurons. This rundown was prevented by supplementing of the 
internal solution with ATP-regenerating agents. The difference in the stability of evoked 
currents in our experiments and those done by Wang et al. could be explained by the 
difference in the nature of the recorded currents. The relative contribution of the 
extrasynaptic and synaptic receptors in the study by Wang et al. is unknown. 
It is worth pointing out the difference between experimental conditions in the 
present study and other studies involving forskolin. First, 3-isobutyl-1-methylxanthine 
(IBMX), a phosphodiesterase inhibitor that enhances the effect of forskolin, was omitted 
from our experiments. Second, the experiments were conducted in the absence of  a
GABAA receptor inhibitor, routinely used in other studies (Carroll et al. 1998; Chavez-
Noriega and Stevens 1994; Chen and Roper 2003; Duffy and Nguyen 2003). Previously,
our group has demonstrated that picrotoxin, presumably acting through the GABAA
receptors, reversed a facilitating effect of Sp-cAMPS on synaptic transmission in the 
CA1 area of hippocampal cultured slices (Yu et al. 2001). Sp-cAMPS is a membrane-
permeable analogue of cAMP which activates PKA by directly binding to its regulatory 
subunit.
In experiments using the perforated patch, 15 min forskolin treatment (50µM) 
consistently produced an enhancement of eEPSC amplitudes. Each of the 6 tested 
neuronal pairs exhibited EP of eEPSCs, and 5 of 6 tested pairs exhibited LP of eEPSCs
following drug application. That the LP was mediated by the cAMP/PKA pathway is 
indicated by the fact that it was blocked by Rp-cAMPS. Rp-cAMPS is a membrane-
permeable non-metabolizable analogue of cAMP which prevents PKA activation. In 
23
contrast to LP, forskolin-induced EP was not completely abolished by Rp-cAMPS 
(36±17% increase of eEPSC amplitudes when both forskolin and Rp-cAMPS were 
present in the perfusion solution, Fig 1a). Upregulation of eEPSCs during forskolin 
perfusion, despite the presence of Rp-cAMPS, could be explained by the PKA-
independent effect of forskolin on synaptic transmission. Such an effect might be 
attributed to the ability of forskolin, a lipophilic substance, to incorporate into the plasma 
membrane and/or directly effect certain types of membrane ion channels (Ono et al. 
1995; Su et al. 2001).
Results of experiments with Rp-cAMPS were used to quantify a PKA-mediated 
component of the forskolin-induced changes of eEPSCs during EP. The PKA-mediated 
component was determined by subtracting a PKA-independent effect of forskolin from 
the total effect of the drug. The results of the effect of forskolin on eEPSC amplitudes
and mEPSC frequency in experiments using different patch-clamp configurations 
(summarized in Table 1) indicate that forskolin-induced EP and LP of eEPSCs are
contributed by modulation of postsynaptic proteins. Indeed, when presynaptic events 
were uncoupled by the whole-cell configuration, both EP and LP of eEPSCs were
equivalent to those in perforated patch experiments (144± 21% (EP) and 53±9% (LP) vs. 
140±10% (EP) and 52±7% (LP) increase of eEPSC amplitudes under the presynaptic 
whole-cell and perforated patch, respectively). Postsynaptic whole-cell, to the contrary, 
abolished both the PKA-dependent component of EP, and LP (10±20% (EP) and -4±6% 
(LP) vs. 104±20% (EP) and 52±7% (LP) PKA-dependent potentiation of eEPSC 
amplitudes under the postsynaptic whole-cell and perforated patch, respectively). A 
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similar conclusion about the mechanism of the late potentiation of eEPSCs by forskolin 
in hippocampal slices was made by Duffy and Nguyen (Duffy and Nguyen 2003).
It is highly improbable that the ineffectiveness of the presynaptic whole-cell 
configuration in disrupting eEPSC potentiation was due to the inability of PKI to reach 
presynaptic terminals as a result of its limited diffusion. In the low-density culture used 
for paired recordings, neuronal network is formed by few closely situated neurons with 
short processes. 25-30 min allowed from the moment of the whole-cell formation to the 
start of forskolin application is enough time for dialyzing even extensive axonal arbors or 
long dendritic trees in slice experiments. That the forskolin effect remained unchanged by 
the presynaptic whole-cell could not be explained by merely the ineffectiveness of PKI. 
Even if the drug was not included in the pipette solution, the lack of ATP and substrates 
for the endogenous ATP-regenerating machinery in the pipette solution is expected to 
uncouple, if not impair, phosphorylation events. The most convincing evidence of the 
effectiveness of the presynaptic whole-cell in dialyzing presynaptic terminals is the 
changed pattern of synaptic responses to the paired-pulse stimulation. Presynaptic whole-
cell configuration disrupted PPF, which was consistently present in neuronal pairs under 
other patch-clamp configurations.
In a minority of experiments (1 of 6 experiments under the perforated patch and 2 
of 5 experiments under the presynaptic whole-cell configuration) forskolin failed to 
produce LP. This variability in the long-term effect of forskolin might be explained by 
the differential effect of the drug on various types of neurons present in culture. Indeed, 
similar to the mature hippocampal formation, developed neuronal cultures might contain 
excitatory neurons of at least two types - pyramidal neurons and granule cells of the 
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dentate gyrus. Thus, variability of the long-term effect of forskolin on eEPSCs could be 
ascribed to the differences in regulation by PKA of the synaptic transmission in these two 
neuronal phenotypes.
The conclusion about the postsynaptic nature of the forskolin-induced EP is 
supported by experiments on mEPSCs. The increase of mEPSC frequency during 
perfusion with forskolin was attenuated when the postsynaptic cell was under the whole-
cell configuration. We attempted to address the concern that this attenuation could be due 
to the rundown or loss of sensitivity of AMPA receptors during the whole-cell recordings 
(Wang et al. 1991), rather than due to a disruption of postsynaptic phosphorylation. To 
avoid distortion by mEPSC rundown under the whole-cell configuration, forskolin was 
applied 30 min after the whole-cell formation, at which time the decline of mEPSC 
frequency was minimal (Fig 3a). The upregulation of mEPSC frequency by forskolin 
applied 30 min after the whole-cell formation was still less pronounced than that in 
perforated patch experiments (194±25% vs. 345±47% increase under the whole-cell and 
perforated patch, respectively, Fig 3a). Such an impairment of the forskolin effect would 
not be expected if the increase of mEPSC frequency took place exclusively as a result of 
the presynaptic processes, because presynaptic neurons remained intact during mEPSC 
recordings. The results of these experiments suggest that almost half the increase of 
mEPSC frequency was contributed by postsynaptic mechanisms. 
From the point viewpoint of classical quantal theory, existence of the postsynaptic 
component of the forskolin-induced enhancement of mEPSC frequency seems 
paradoxical. Classical quantal theory is based on the assumption that the total number of 
active synapses in a preparation remains unchanged. Hence, variability of mEPSC 
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frequency would originate only from a changed probability of transmitter release. The 
assumption about the constancy of active synapses, however, has been disproven for 
central synapses. For example, in the hippocampus, one of the mechanisms of synaptic 
potentiation is induction of postsynaptically silent synapses (Faber et al. 1991; Isaac et al. 
1995). 
The same mechanism might have contributed to the forskolin-induced 
potentiation of mEPSC frequency observed under the perforated patch. Although the role 
of PKA in the induction of silent synapses has not been demonstrated, its role in 
membrane targeting of AMPA receptors is well established. For example, 
phosphorylation by PKA of the GluR4 AMPA receptor subunit was necessary and 
sufficient for its incorporation into synapses (Esteban et al. 2003). In addition, PKA 
regulates GluR1 recycling between the plasma membrane and endosomal compartments 
in dissociated hippocampal neurons (Ehlers 2000).
Our data suggest that the enhancement of mEPSC frequency by 194±25%, 
observed under the whole-cell configuration, was contributed by presynaptic 
mechanisms. One general class of such mechanism, an upregulation of the probability of 
spontaneous transmitter release, might result from accelerated vesicle cycling at the ready 
releasable pool of neurotransmitter. Such an effect of PKA activation has been 
demonstrated in cerebellar granule cells (Chavis et al. 1998). Another class of presynaptic 
mechanism, the induction of new or silent release sites, has been reported for
hippocampal cultured neurons (Kohara et al. 2001; Ma et al. 1999). This effect of 
forskolin, however, was demonstrated in young (<14 days) or pharmacologically silenced 
neurons, and was absent in more mature non-silenced neurons. Thus, induction of new or 
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silent release sites could not contribute to the enhancement of mEPSC frequency in our 
experiments.
The conclusion regarding the presynaptic component of the forskolin-induced 
upregulation of mEPSC frequency should be distinguished from our results with paired 
recordings, which reveals little or no presynaptic contribution. We note that increased
spontaneous, calcium-independent transmitter release, observed during mEPSC 
recording, does not necessarily contribute to stimulus-induced, calcium-dependent 
transmitter release, which determines eEPSC amplitudes. For example, enhancement of 
mEPSC frequency might result from accelerated vesicle cycling and a subsequent 
increased availability of synaptic vesicles at the ready releasable pool of neurotransmitter. 
However, only if vesicle availability is a limiting factor in evoked transmitter release will 
such a mechanism change eEPSC amplitudes. Vesicle availability may not be limiting in 
our experiments using a moderate rate of stimulation (once every 30 s). The limiting 
factors for the induced transmitter release during paired recordings might rather be the 
amplitude of the stimulus-induced calcium transients at the presynaptic release sites, or 
the effectiveness of these calcium transients to trigger synaptic vesicle exocytosis
(reviewed by (Atwood and Karunanithi 2002). 
Having established the role of postsynaptic events, we attempted to address 
whether modulation of glutamate receptors was one of those postsynaptic events 
contributing to the forskolin-induced upregulation of eEPSCs and mEPSCs. PKA is 
targeted to AMPA receptors by means of the A kinase anchoring protein and other 
scaffolding proteins of the postsynaptic density (Colledge et al. 2000). Phosphorylation 
by PKA of the GluR1 AMPA receptor subunit at Ser 845 increased the peak open 
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probability of the receptor channel opening, a change expected to increase macroscopic 
current through these receptors (Banke et al. 2000). 
Despite ample evidence that AMPA receptors are targeted by PKA, activation of 
this enzyme did not increase mEPSC amplitudes in CA1 pyramidal neurons treated with 
forskolin (Carroll et al. 1998). We also found no detectable increase of mEPSC 
amplitudes in experiments in high-density cultures (data not shown). We hypothesize that 
the failure to detect potentiation of mEPSC amplitudes in mature neurons could arise 
from two factors: low signal-to-noise ratio of mEPSC recordings and dendritic filtering. 
This hypothesis is supported by the report that, in very young hippocampal cultures (2-7 
days in vitro), in which the dendritic filtering is minimal, forskolin did potentiate mEPSC 
amplitudes (Greengard et al. 1991). To avoid the problems of low signal-to-noise ratio 
and dendritic filtering, we studied the effect of forskolin on mEPSCs in low-density 
cultures. Neurons in such cultures possess only few, relatively short processes, providing 
mEPSC records devoid of most dendritic filtering. We have now demonstrated that, in 
such low-density cultures, PKA activation with forskolin enhanced mEPSC amplitudes. 
As expected, this effect of forskolin was disrupted by the whole-cell configuration (Fig 
4b).
The differential effect of forskolin on mEPSC amplitudes in high- and low-
density cultures might arise from developmental differences in these cultures, as well as 
from the electrophysiological considerations discussed above. For example, GluR1 
AMPA receptors may be constitutively and maximally phosphorylated by PKA in a 
mature hippocampus (Carroll et al. 1998; Mammen et al. 1997). If this also applied to the 
high-density cultures, it could explain the absence of the forskolin effect on mEPSC 
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amplitudes. However, our Western blot immunostaining argues against constitutive and 
maximal level of phosphorylation of GluR1 AMPA receptors. As revealed with the anti-
P-GluR1Ser845 antibody, forskolin treatment of high density cultures resulted in an extra 
band in the Western blot of electrophoretically separated whole-cell lysates indicating 
increased phosphorylation of the GluR1 subunit (Fig 4a). An increase of the anti-P-
GluR1Ser845 signal following forskolin treatment has also been demonstrated in mature 
rat hippocampal slices (Lee et al. 1998).
It is widely acknowledged that activation of the calcium and calmodulin-
dependent protein kinase II (CaMKII), mediated by NMDA receptors, is necessary for 
activity-induced LTP in the hippocampus (Bliss and Collingridge 1993; Silva et al. 
1992). We tested whether forskolin-induced LP of eEPSCs is NMDA receptor dependent. 
NMDA receptor activation might be triggered by an increase in spontaneous firing which 
accompanies forskolin treatment of cultures during paired recordings. Such a mechanism 
for the forskolin-induced late phase of potentiation in the CA1 area of the hippocampus 
has been recently reported by Otmakhov and colleagues (Otmakhov et al. 2003). 
Enhanced spontaneous activity, which manifests itself as an increase of the 
frequency and amplitudes of spontaneous EPSCs, was also observed in our experiments. 
We argue, however, that, since during paired recordings the neurons were voltage-
clamped at -60 mV, activation of these receptors was hardly possible due to a block of 
NMDA receptors by magnesium ions. In addition, increase of spontaneous EPSCs was 
not associated with spontaneous action potential generation. In fact, under no conditions 
during the experiments in the low-density culture, did neurons spontaneously fire action 
potentials (some regions of cultured cells typically escape voltage clamp, and such 
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unclamp action potentials are revealed as transient inward currents). Nevertheless, we 
could not completely exclude the possibility of NMDA receptor activation during 
enhanced spontaneous activity, because, at a concentration of external Mg2+ used in our 
experiments (0.5 mM), a small fraction NMDA receptors might remain unblocked even 
at high negative membrane potentials (Hestrin et al. 1990).
Our data do not confirm a role of NMDA receptors in the forskolin-induced LP in 
hippocampal cultures. The NMDA receptor blocker AP-5 (50 µM) did not alter forskolin-
induced LP (Fig 4c). The observed potentiation of eEPSCs was also stimulus-
independent. In fact, LP was even more pronounced if the presynaptic neuron was not 
stimulated during and 40 min after, forskolin treatment (Fig 4c).
In summary, results presented here challenge the conclusion of previous
electrophysiological studies that the forskolin-induced potentiation of synaptic 
transmission is mediated by presynaptic mechanisms (Carroll et al. 1998, Chavez-
Noriega and Stevens 1994). We have demonstrated that postsynaptic mechanisms are 
essential for the forskolin-induced  potentiation of eEPSCs in hippocampal embryonic 
neuronal cultures. Phosphorylation of the GluR1 subunit of AMPA receptors, subsequent 
upregulation of their function and/or their membrane targeting are among the possible 
mechanisms contributing to the effect of forskolin on synaptic currents in hippocampal 
cultured neurons.
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Figure Legends.
Figure 1 a. Effect of forskolin (50 µM) on eEPSCs in perforated patch experiments. 15 
min forskolin treatment resulted in a 140±10 % increase of eEPSC amplitudes (6 cell 
pairs). eEPSC amplitudes declined during the first 10 min upon forskolin washout and 
then stabilized at a potentiated level, which exceeded the baseline by 52±7% 60 min after 
forskolin washout (5 of 6 cell pairs). LP was abolished if forskolin was applied with the 
PKA inhibitor Rp-cAMPS (50 µM), indicating that the forskolin-induced LP was 
mediated by the cAMP/PKA pathway. An early forskolin-induced potentiation of 
eEPSCs by 36±17% of baseline (3 cell pairs) on the background of Rp-cAMPS might be 
explained by the PKA-independent effect of forskolin, presumably on ion channels. In 
control experiments, long-term eEPSC measurements were done in untreated cultures.
Only the last 10 min (of the total 25-30 min prior to the drug application) of baseline 
recordings are reflected in the Figure.
Insert: representative eEPSCs during baseline recordings, after 15 min in forskolin (EP), 
and 60 min after forskolin washout (LP).
b. Effect of forskolin on mEPSC frequency in hippocampal cultured neurons under the 
perforated patch.15 min of forskolin treatment led to an increase of mEPSC frequency to 
445±47% of baseline. mEPSC frequency then steadily declined upon forskolin washout 
reaching the pre-treatment level about 45 min after forskolin washout. Numbers over the 
data points indicate the number of experiments included in the analysis. There was no 
detectable effect of forskolin on mEPSC amplitudes (data not shown).
 In control experiments, long-term recordings of mEPSCs were done in untreated 
cultures. mEPSC frequency steadily declined in these cultures, starting at about 30 min 
after being placed in the bathing solution. mEPSC frequency constituted 68±5% of the 
baseline (5 cell pairs) 60 min after the start of experiments. The insert shows
representative mEPSC traces before and after the forskolin treatment.
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Figure 2. a) Effect of forskolin on eEPSCs in experiments with the presynaptic or the 
postsynaptic neuron under the whole-cell configuration. Under the presynaptic whole-cell 
configuration, forskolin induced EP comparable to that under the perforated patch 
(eEPSC increased by 144 ± 21% of baseline, 6 cell pairs). In 4 of the 6 cell pairs
forskolin also induced LP (eEPSC increased by 53 ± 9 % of baseline). In contrast to the 
presynaptic whole-cell, the postsynaptic whole-cell configuration impaired EP and 
disrupted LP. eEPSC amplitudes increased only by 46±11% of baseline (4 cell pairs) 
during the EP. As derived from experiments with Rp-cAMPS, most of this increase (by 
36±17% of baseline) was contributed by the PKA-independent mechanisms. b) Results of 
control experiments, in which long-term recordings of eEPSCs were done in untreated 
cultures. In these experiments, at times corresponding to LP, eEPSC amplitudes 
constituted 102 ± 6 % and 108 ± 7 % of baseline under the presynaptic and postsynaptic 
whole-cell configuration, respectively (2 cell pairs in each configuration). These 
experiments demonstrated that the baseline level of eEPSCs was not affected by 
conditions of the whole-cell configuration.
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Figure 3 a) Effect of forskolin on mEPSC frequency in experiments using the whole-cell
configuration. In control experiments (no forskolin), there was a decline of mEPSC 
frequency to 63±8 % of the initial level during the first 30 min after the whole-cell 
formation (8 experiments). mEPSC frequency then stabilized; the decline of mEPSC 
frequency during the next 15 min was only 4.5±8 % of baseline (8 experiments). To 
avoid a contribution of mEPSC rundown during the whole-cell experiments, forskolin 
was not applied until 30 min after the whole-cell formation. The rate of mEPSCs prior to
forskolin application was considered a baseline. After 15 min of forskolin treatment, the 
upregulation of mEPSC frequency under the whole-cell configuration was significantly 
lower than that under the perforated patch (194±25 % of baseline, 5 experiments, vs. 
345±47% of baseline, 5 experiments, p<0.01). b) Representative current traces recorded
during a simultaneous whole-cell and perforated patch experiment. Such experiments 
using dual-cell voltage-clamp were conducted to avoid a contribution of dish-to-dish 
variability to the differential effect of forskolin on mEPSCs under the two patch-clamp 
configurations. Forskolin-induced increase of mEPSC frequency was significantly higher 
in experiments using the perforated patch than in those using the whole-cell configuration 
(1.45±0.11 times, p<0.05, 3 experiments). These results demonstrate that postsynaptic 
events contribute to the forskolin-induced potentiation of mEPSC frequency.
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Figure 4 a) Western blots of the whole-cell protein extracts from untreated cultures (left 
lanes), cultures treated with forskolin and lysed immediately (middle lanes), or 45 min 
after forskolin treatment (right lanes). Equal amounts of the indicated protein extracts 
were loaded onto three different gels. The first blot was immunostained with the anti-
phospho-GluR1 antibody specific for phosphorylated Ser845 (top panel). To confirm the 
specificity of the anti-phospho-GluR1 (Ser845) antibody staining, the second blot was 
incubated with the antibody-containing solution supplemented with the anti-phospho-
GluR1 immunizing peptide at saturating concentration (1 µM) (middle panel). To 
demonstrate that approximately equal amounts of GluR1 protein were present in the 
lanes, the third membrane blot was immunostained with the anti-GluR1 antibody (bottom
panel). As indicated by the extra band corresponding to ~ 108 kDa molecular weight, 
present in the middle lane of the top panel, forskolin treatment induced phosphorylation 
of the GluR1 subunit of AMPA receptors,. Phosphorylation of GluR1 was negligible 45 
min after forskolin washout (top panel, right lane). The intensities of the anti-GluR1 
specific bands (lower panel), as well as of the non-specific bands in all three blots, 
demonstrate that about equal amounts of GluR1 and the total protein were present in the 
blots.
b) Cumulative probabilities of mEPSC amplitudes in control (filled circles) and after 
forskolin treatment (blank circles) under the perforated patch (left panel) and the whole-
cell configuration (right panel) in low-density cultures. Forskolin significantly increased 
mEPSC amplitudes in the perforated patch experiments (p<0.05, Kolmogorov-Smirnov 
test, 3 experiments). Under the whole-cell configuration, to the contrary, mEPSC 
amplitudes experiments were unaffected by forskolin (2 experiments, right panel). There 
was no detectable effect of forskolin on mEPSC amplitudes in high-density cultures, 
presumably, due to a combination of the low signal-to-noise ratio and dendritic filtering 
of mEPSCs in these experiments.
c) Experiments demonstrating that forskolin-induced potentiation of eEPSC amplitudes 
was independent of neuronal activity (open circles) or NMDA receptor function (filled 
circles). After baseline recording stimulation of the presynaptic neuron was interrupted
until 45 min after forskolin washout. Under these conditions LP constituted 211±17 % (3 
experiments) 60 min after forskolin washout. Inhibition of NMDA receptors by AP-5 did 
not disrupt the effect of forskolin on eEPSC amplitudes, which indicates that potentiation 
of eEPSCs was not mediated by NMDA receptors. 
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Table 1. Summary of the results of experiments on the effect of forskolin on eEPSCs and 
mEPSCs using different patch-clamp configurations.
* calculated as the difference between the total effect of forskolin and the PKA-
independent effect established in experiments using Rp-cAMPS.
       configuration potentiation (% of baseline)
EP LP
Type 
of 
expe-
riment
treatment pre-
synaptic
post-
synaptic total PKA-depend total
mechanism
of potentiation
forskolin perforated perforated 140±10 104±20* 52±7 pre- &postsynaptic
forskolin+
Rp-
cAMPS
perforated perforated 36±17 0 0 pre- &postsynaptic
forskolin whole-cell perforated 144±21 108±27* 53±9 postsynaptice
EP
SC
forskolin perforated whole-cell 46±11 10±20* -4±6 presynaptic
forskolin+
TTX intact perforated 345±47 - 0
pre- &
postsynaptic
m
EP
SC
forskolin+
TTX intact whole-cell 194±25 -
- presynaptic
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